Barclays’s Kezar Life Sciences KZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$0 Hold
1
﹤0.01% 4454
2025
Q1
$0 Hold
1
﹤0.01% 4470
2024
Q4
$0 Buy
+1
New ﹤0.01% 4420
2024
Q3
Sell
-22
Closed 4378
2024
Q2
$0 Sell
22
-4,990
-100% ﹤0.01% 4253
2024
Q1
$45K Sell
5,012
-4,792
-49% -$43K ﹤0.01% 3838
2023
Q4
$93K Buy
9,804
+8,545
+679% +$81.1K ﹤0.01% 3727
2023
Q3
$15K Sell
1,259
-164
-12% -$1.95K ﹤0.01% 3956
2023
Q2
$35K Sell
1,423
-81,480
-98% -$2M ﹤0.01% 3818
2023
Q1
$2.59M Buy
82,903
+64,154
+342% +$2.01M ﹤0.01% 1476
2022
Q4
$1.32M Buy
18,749
+3,428
+22% +$241K ﹤0.01% 1922
2022
Q3
$1.32M Buy
15,321
+14,918
+3,702% +$1.28M ﹤0.01% 1929
2022
Q2
$33K Sell
403
-212
-34% -$17.4K ﹤0.01% 3899
2022
Q1
$102K Sell
615
-3,631
-86% -$602K ﹤0.01% 3658
2021
Q4
$710K Buy
4,246
+1,046
+33% +$175K ﹤0.01% 2367
2021
Q3
$277K Buy
3,200
+961
+43% +$83.2K ﹤0.01% 2837
2021
Q2
$122K Sell
2,239
-2,199
-50% -$120K ﹤0.01% 3075
2021
Q1
$264K Buy
4,438
+1,607
+57% +$95.6K ﹤0.01% 3010
2020
Q4
$148K Sell
2,831
-381
-12% -$19.9K ﹤0.01% 2841
2020
Q3
$155K Sell
3,212
-180
-5% -$8.69K ﹤0.01% 2861
2020
Q2
$175K Buy
3,392
+561
+20% +$28.9K ﹤0.01% 2872
2020
Q1
$124K Sell
2,831
-550
-16% -$24.1K ﹤0.01% 2735
2019
Q4
$135K Buy
3,381
+787
+30% +$31.4K ﹤0.01% 3342
2019
Q3
$85K Buy
2,594
+90
+4% +$2.95K ﹤0.01% 3479
2019
Q2
$193K Buy
2,504
+2,148
+603% +$166K ﹤0.01% 3217
2019
Q1
$63K Buy
+356
New +$63K ﹤0.01% 3547
2018
Q4
Sell
-193
Closed -$41K 4234
2018
Q3
$41K Buy
+193
New +$41K ﹤0.01% 3790